APA (7th ed.) Citation

Watanabe, F., Suzuki, K., Tamaki, S., Abe, I., Endo, Y., Takayama, Y., . . . Rikiyama, T. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Watanabe, Fumiaki, et al. Longitudinal Monitoring of KRAS-mutated Circulating Tumor DNA Enables the Prediction of Prognosis and Therapeutic Responses in Patients with Pancreatic Cancer. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Watanabe, Fumiaki, et al. Longitudinal Monitoring of KRAS-mutated Circulating Tumor DNA Enables the Prediction of Prognosis and Therapeutic Responses in Patients with Pancreatic Cancer. Public Library of Science (PLoS).